The questions concerning mild HBOT are the very same as those that are voiced when talking of normal HBOT therapy and treatment. The obvious points of concern are the duration, frequency and effectiveness of mild HBOT therapy. This article aims to provide relevant information about the rather controversial treatment method.
Mild Hyperbaric Oxygen Therapy, by definition, signifies the administration of pure oxygen ranging between 1.3 to 1.5 ATA. Any dosage that does not determine a full 100% of oxygen can not be termed as hyperbaric. Medical protocols do not even consider such treatments as hyperbaric, but call them compressed-air therapy. This, however, does not mean that 100% oxygen can not be injected into monoplace hyperbaric chambers at levels lower than 1.5ATA. However, such risks are not taken in the case of these soft-portable chambers that are designed to function effectively under pressure statistics ranged between 1.3 to 1.5ATA. The result is that what is referred to as mild HBOT does not fit the basic definition of HBOT therapy, which is, administering 100% pure oxygen to patients in acrylic chambers to improve circulation of blood and oxygen to organs and injured parts to improve health and accelerate the normal recovery process of damaged tissues and cells.
This may be slightly confusing for patients who have the impression of receiving oxygen dose that is close to, if not a full 100% when they decide to undergo mild HBOT therapy in soft-portable chambers. Patients are generally asked to wear masks that are connected to an extraneous oxygen tank, or oxygen concentrator. The first misconception that needs to be cleared is that these concentrators deliver oxygen ranged from 85% -95%, but never a complete 100%. The second misconception is with regard to the purity of the oxygen that is being inhaled. Oxygen masks do not really set down tightly around the nose and mouth area, with the result that there is some amount of infiltration of normal atmospheric gases in the normal oxygen that is being delivered from the tank. This mixture of ambient air normally brings down the purity quotient of oxygen to any level between 40% -60%. This, however should not deter patients from opting for HBOT therapy as inhalation of pure oxygen in any amount is always beneficial for health.
Mild HBOT therapy yields the same results as hard hyperbaric therapy sessions where oxygen is delivered under higher atmospheric pressures ranging between 2-4ATA. According to archived data, SPECT (Single Photo Emission Computed Tomography) scans after 40 sessions of mild HBOT show significant improvement in blood and oxygen supply to the temporal lobe of the brain, where an individual's short-term memory is located. There is visible recovery from memory loss suffered by patients with brain injury.
Mild HBOT therapy also improves the immunity of the body, reduces inflammations, and facilitates improvement in patients with ulcerative and Crohn's colitis.
This therapy has shown a remarkable increase in the glutathione levels (15%) for a period as long as 24 hours after the commenment of the hyperbaric session. These facts are important for parents with children suffering from autism.
Mild HBOT therapy is primarily administered in soft- portable chambers that are designed to be used at home for cases that require extensive hours of treatment. However, it is best to go through the initial sessions in a clinic under the care of trained test-administrators. Best suited for children with autism spectrum disorder, mild HBOT chambers offer an extra opportunity to parents to emotionally support their autistic child who are in constant need of reiteration of emotional belonging.